Cargando…
Argon–Helium Cryoablation for Cutaneous Squamous Cell Carcinoma in the Elderly
Cutaneous squamous cell carcinoma (cSCC) is a common type of malignant neoplasm in non-melanoma skin cancer (NMSC). Most cases of simple cSCC are considered curable by surgical removal of the lesion. However, clinical treatments for cSCC with medium- or large-sized lesions are difficult. Meanwhile,...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795517/ https://www.ncbi.nlm.nih.gov/pubmed/35096587 http://dx.doi.org/10.3389/fonc.2021.788490 |
_version_ | 1784641083570913280 |
---|---|
author | Huang, Qianwen Xu, Wenshen |
author_facet | Huang, Qianwen Xu, Wenshen |
author_sort | Huang, Qianwen |
collection | PubMed |
description | Cutaneous squamous cell carcinoma (cSCC) is a common type of malignant neoplasm in non-melanoma skin cancer (NMSC). Most cases of simple cSCC are considered curable by surgical removal of the lesion. However, clinical treatments for cSCC with medium- or large-sized lesions are difficult. Meanwhile, the effectiveness of the treatments is not guaranteed, especially for elderly patients, because of an intolerance to surgical resection or other adjuvant modalities. In such cases, safe and effective treatments with excellent aesthetic outcomes are urgently needed. In this study, we reported 6 elderly cSCC patients with medium- or large-sized lesions treated with argon–helium cryoablation. The average age of all 6 patients was 78 years (range 72–85 years). They were all diagnosed with cSCC with a median tumor size of 5.8 cm (range 2.5–15.5 cm) and dermal invasion. Complete ablation was achieved in all cases after a single ablation session (2 freeze–thaw cycles). Patients experienced mild pain and hemorrhage after ablation, but the symptoms were manageable. One patient developed infection and fever because of extensive necrosis of the tumor, which was eventually cured after treatment. All patients obtained good cosmetic outcomes, and their quality of life improved significantly. In the 5-year follow-up study, 4 patients were alive while 2 patients died of unrelated diseases 3 years after cryotherapy. None of the 6 patients had a recurrence. These results suggested the feasibility of argon–helium cryoablation as a novel therapeutic strategy for elderly cSCC with medium- or large-sized lesions. |
format | Online Article Text |
id | pubmed-8795517 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87955172022-01-29 Argon–Helium Cryoablation for Cutaneous Squamous Cell Carcinoma in the Elderly Huang, Qianwen Xu, Wenshen Front Oncol Oncology Cutaneous squamous cell carcinoma (cSCC) is a common type of malignant neoplasm in non-melanoma skin cancer (NMSC). Most cases of simple cSCC are considered curable by surgical removal of the lesion. However, clinical treatments for cSCC with medium- or large-sized lesions are difficult. Meanwhile, the effectiveness of the treatments is not guaranteed, especially for elderly patients, because of an intolerance to surgical resection or other adjuvant modalities. In such cases, safe and effective treatments with excellent aesthetic outcomes are urgently needed. In this study, we reported 6 elderly cSCC patients with medium- or large-sized lesions treated with argon–helium cryoablation. The average age of all 6 patients was 78 years (range 72–85 years). They were all diagnosed with cSCC with a median tumor size of 5.8 cm (range 2.5–15.5 cm) and dermal invasion. Complete ablation was achieved in all cases after a single ablation session (2 freeze–thaw cycles). Patients experienced mild pain and hemorrhage after ablation, but the symptoms were manageable. One patient developed infection and fever because of extensive necrosis of the tumor, which was eventually cured after treatment. All patients obtained good cosmetic outcomes, and their quality of life improved significantly. In the 5-year follow-up study, 4 patients were alive while 2 patients died of unrelated diseases 3 years after cryotherapy. None of the 6 patients had a recurrence. These results suggested the feasibility of argon–helium cryoablation as a novel therapeutic strategy for elderly cSCC with medium- or large-sized lesions. Frontiers Media S.A. 2022-01-14 /pmc/articles/PMC8795517/ /pubmed/35096587 http://dx.doi.org/10.3389/fonc.2021.788490 Text en Copyright © 2022 Huang and Xu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Huang, Qianwen Xu, Wenshen Argon–Helium Cryoablation for Cutaneous Squamous Cell Carcinoma in the Elderly |
title | Argon–Helium Cryoablation for Cutaneous Squamous Cell Carcinoma in the Elderly |
title_full | Argon–Helium Cryoablation for Cutaneous Squamous Cell Carcinoma in the Elderly |
title_fullStr | Argon–Helium Cryoablation for Cutaneous Squamous Cell Carcinoma in the Elderly |
title_full_unstemmed | Argon–Helium Cryoablation for Cutaneous Squamous Cell Carcinoma in the Elderly |
title_short | Argon–Helium Cryoablation for Cutaneous Squamous Cell Carcinoma in the Elderly |
title_sort | argon–helium cryoablation for cutaneous squamous cell carcinoma in the elderly |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795517/ https://www.ncbi.nlm.nih.gov/pubmed/35096587 http://dx.doi.org/10.3389/fonc.2021.788490 |
work_keys_str_mv | AT huangqianwen argonheliumcryoablationforcutaneoussquamouscellcarcinomaintheelderly AT xuwenshen argonheliumcryoablationforcutaneoussquamouscellcarcinomaintheelderly |